\documentclass[10pt]{article}

\usepackage{fullpage}
\usepackage{setspace}
\usepackage{parskip}
\usepackage{titlesec}
\usepackage[section]{placeins}
\usepackage{xcolor}
\usepackage{breakcites}
\usepackage{lineno}
\usepackage{hyphenat}





\PassOptionsToPackage{hyphens}{url}
\usepackage[colorlinks = true,
            linkcolor = blue,
            urlcolor  = blue,
            citecolor = blue,
            anchorcolor = blue]{hyperref}
\usepackage{etoolbox}
\makeatletter
\patchcmd\@combinedblfloats{\box\@outputbox}{\unvbox\@outputbox}{}{%
  \errmessage{\noexpand\@combinedblfloats could not be patched}%
}%
\makeatother


\usepackage{natbib}




\renewenvironment{abstract}
  {{\bfseries\noindent{\abstractname}\par\nobreak}\footnotesize}
  {\bigskip}

\titlespacing{\section}{0pt}{*3}{*1}
\titlespacing{\subsection}{0pt}{*2}{*0.5}
\titlespacing{\subsubsection}{0pt}{*1.5}{0pt}


\usepackage{authblk}


\usepackage{graphicx}
\usepackage[space]{grffile}
\usepackage{latexsym}
\usepackage{textcomp}
\usepackage{longtable}
\usepackage{tabulary}
\usepackage{booktabs,array,multirow}
\usepackage{amsfonts,amsmath,amssymb}
\providecommand\citet{\cite}
\providecommand\citep{\cite}
\providecommand\citealt{\cite}
% You can conditionalize code for latexml or normal latex using this.
\newif\iflatexml\latexmlfalse
\providecommand{\tightlist}{\setlength{\itemsep}{0pt}\setlength{\parskip}{0pt}}%

\AtBeginDocument{\DeclareGraphicsExtensions{.pdf,.PDF,.eps,.EPS,.png,.PNG,.tif,.TIF,.jpg,.JPG,.jpeg,.JPEG}}

\usepackage[utf8]{inputenc}
\usepackage[ngerman,english]{babel}








% Edit this header.tex file to include frontmatter definitions and global macros

% Add here any LaTeX packages you would like to load in all document blocks
% \usepackage{xspace}

% Add here any LaTeX macros you would like to load in all document blocks
% \def\example{This is an example macro.}

% -----

\iflatexml
% Add here any LaTeXML-specific commands

% -----

\else
% Add here any export style-specific LaTeX commands. These will only be loaded upon document export. 
% \paperfield{Subject domain of my document}
% \keywords{keyword1, keyword2}
% \corraddress{Author One PhD, Department, Institution, City, State or Province, Postal Code, Country}
% \fundinginfo{Funder One, Funder One Department, Grant/Award Number: 123456.}
\fi


\begin{document}

\title{Let's meet\ldots{} Tom Mindt}



\author[1]{SRSTT Radiopharmaconnect}%
\affil[1]{Radiopharmaconnect}%


\vspace{-1em}



  
  \date{March 14, 2025}


\begingroup
\let\center\flushleft
\let\endcenter\endflushleft
\maketitle
\endgroup








\sloppy


\selectlanguage{english}
\begin{figure}[h!]
\begin{center}
\includegraphics[width=0.28\columnwidth]{figures/Picture1/Picture1}
\caption{{{\emph{Thomas Mindt}}
{\label{847101}}%
}}
\end{center}
\end{figure}

\par\null

\section*{Hi Thomas, what excites you about your work? What is your
favourite aspect of your
research?}

{\label{971075}}\par\null

\begin{quote}
Radiopharmaceutical sciences is an interdisciplinary research field at
the interface of chemistry, biology, and medicine. Therefore it requires
interactions and exchange with scientists of different fields. This can
be a challenge, but definitely very rewarding. Radiopharmaceutical
science~is application-driven, meaning that research efforts are
focussed on the eventual translation of new molecular imaging probes
(and radiotherapeutics) into the clinic. As a result, promising new
compounds undergo biological evaluation and do not simply end up in the
freezer for storage after the publication of the synthesis.
\end{quote}

\par\null

\section*{What is your vision of the future of
radiochemistry/radiopharmacy/nuclear
medicine?}

{\label{286835}}\par\null

\begin{quote}
These research fields are currently rapidly expanding thanks to recent
developments (e.g., approved radiolabelled octreotides and PSMA
ligands). Personalized medicine is not a buzz word but has become the
focus of new approaches to address future challenges faced globally by
healthcare systems. I strongly believe that nuclear medicine, and thus
radiopharmaceuticals sciences, will play a pivotal role in this.
\end{quote}

\par\null

\section*{What is your opinion on why young researcher should choose
radiochemistry/radiopharmacy/nuclear medicine as their research
discipline?~}

{\label{660907}}\par\null

\begin{quote}
Non-invasive imaging is an important (and cool) diagnostic tool!
\emph{Theranostic approaches} in nuclear medicine go a step further by
applying the developed radiopharmaceuticals also for targeted nuclear
therapy. All that to the benefit of patients. Diagnosis and therapy -
does it get any better?~
\end{quote}

\section*{}

{\label{923403}}

\section*{Do you have any encouraging~advices for young researchers to
succeed in the world of
science?~}

{\label{976834}}\par\null

\begin{quote}
Be curious and persistent. Stay informed what is going on in other
research fields and expand your knowledge whenever possible. Good
observation skills and being critical to reported (also your own) data
often pays off.~
\end{quote}

\section*{If I were not a scientist,}

{\label{927673}}

\begin{quote}
\emph{} I would likely be a chef or cartoonist.
\end{quote}

\par\null\par\null\par\null\par\null

\section*{Biosketch}

{\label{229517}}

\textbf{Full Name}

Thomas~Mindt~

\textbf{Date of birth:~}

May 27th, 1969

\textbf{Positions}:

2016-present: Head Imaging Biomarkers, Ludwig Boltzmann Institute
Applied Diagnostics, Vienna, Austria

2009-2015: Professor in Radiochemistry, University of Basel, Basel,
Switzerland

\textbf{Education}:

M.Sc. in Organic Chemistry, University of Applied Science, Z\selectlanguage{ngerman}ürich,
Switzerland

Ph.D.in Organic Chemistry, Brown University, Providence (RI), USA

Postdoctoral Fellow in Radiopharmaceutical Sciences, ETH Zurich,
Switzerland.~

\textbf{Research}:

Development of peptide- and protein-based radiopharmaceuticals for
theranostic approaches in nuclear oncology

\textbf{Hobbies}:

Science in general (and Pool Billiards, which is applied physics anyway)

\selectlanguage{english}
\FloatBarrier
\end{document}

